S&P 5007,683.69▼0.8% Nasdaq26,820.38▼0.9% Dow51,481.51▼0.7% Russell 2K2,817.91▼0.7% 10-Yr5.24%+6bp VIX16.07+1.20 WTI$93.42▲1.1% Gold$4,147.50▼4.0% EUR/USD1.137▼0.1% BTC$83,823▲0.2% Nikkei65,339▼1.6%
At close · Tue, Sep 29, 2026
Daily Market Updates.

ETFs & Funds

Home›ETFs & Funds›Fund Industry›Citi urges investors to sell Moderna after stock surge

Citi urges investors to sell Moderna after stock surge

Reported · Written up by our desk · Fund Industry

MarketWatch reports that Citi’s analysts told investors it is time to sell Moderna, citing that the stock’s run has outpaced the underlying fundamentals.

According to the outlet, Citi argues Moderna’s revenue and profit forecasts do not justify the level of hype reflected in the shares after gains of more than 600%.

← Newer storyBenefits TPA CEO pleads guilty to $8.8M ERISA fraud

More like this

ETFs & FundsEconomist backs U.S. tech and gold, shuns government bonds
ETFs & FundsNifty 50 SIP XIRR falls below bank FD returns over 5 years
ETFs & FundsYorkville Ives prices a fund targeting private AI-company exposure
ETFs & FundsEllington veteran highlights shift from investment grade to junk
ETFs & FundsKotak AMC MD Nilesh Shah warns against chasing “once in a lifetime” deals

Sources

MarketWatchCiti tells investors it’s time to sell Moderna after 600%-plus stock gains
MarketWatchCiti tells investors it’s time to sell Moderna after 600%-plus stock gains

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.